Berobenatide
A Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW)
Pfizer · Phase 3 · Recruiting · Enrollment 180
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.